GPC3 and Cirrhosis: Tumor size is also included as a major feature of LI-RADS since the likelihood of malignancy in a cirrhosis-associated nodule is positively correlated with the size of the observation (43), but the tumor size exceeding 3.0 cm was considered to be more likely associated with negative GPC-3 expression in our study.